Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines
- PMID: 16288035
- DOI: 10.1158/0008-5472.CAN-05-1718
Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines
Abstract
Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases that play key roles in proliferation, differentiation, and tumorigenesis. FGFR3 was identified as the major family member expressed in both normal human urothelium and cultured normal human urothelial (NHU) cells and was expressed as the IIIb isoform. We also identified a splice variant, FGFR3 Delta8-10, lacking exons encoding the COOH-terminal half of immunoglobulin-like domain III and the transmembrane domain. Previous reports have assumed that this is a cancer-specific splice variant. We showed that FGFR3 Delta8-10 is a normal transcript in NHU cells and is translated, N-glycosylated, and secreted. Primary urothelium expressed high levels of FGFR3 transcripts. In culture, levels were reduced in actively proliferating cells but increased at confluence and as cells approached senescence. Cells overexpressing FGFR3 IIIb showed FGF1-induced proliferation, which was inhibited by the addition of FGFR3 Delta8-10. In bladder tumor cell lines derived from aggressive carcinomas, there were significant alterations in the relative expression of isoforms including an overall decrease in the proportion of FGFR3 Delta8-10 and predominant expression of FGFR3 IIIc in some cases. In summary, alternative splicing of FGFR3 IIIb in NHU cells represents a normal mechanism to generate a transcript that regulates proliferation and in bladder cancer, the ratio of FGFR3 isoforms is significantly altered.
Similar articles
-
Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.Cancer Res. 1994 Oct 1;54(19):5206-11. Cancer Res. 1994. PMID: 7923141
-
Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.Mol Cell Biol Res Commun. 2001 Nov;4(6):365-73. doi: 10.1006/mcbr.2001.0306. Mol Cell Biol Res Commun. 2001. PMID: 11703096
-
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.Cancer Res. 2002 Jul 15;62(14):4123-31. Cancer Res. 2002. PMID: 12124351
-
Fibroblast growth factor receptor-3 in urothelial tumorigenesis.Urol Oncol. 2013 Apr;31(3):303-11. doi: 10.1016/j.urolonc.2011.12.001. Epub 2012 Jan 30. Urol Oncol. 2013. PMID: 22285006 Review.
-
Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.Exp Cell Res. 2005 Apr 1;304(2):417-31. doi: 10.1016/j.yexcr.2004.11.012. Epub 2004 Dec 16. Exp Cell Res. 2005. PMID: 15748888 Review.
Cited by
-
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.Br J Cancer. 2012 Mar 13;106(6):1224-33. doi: 10.1038/bjc.2012.40. Epub 2012 Feb 21. Br J Cancer. 2012. PMID: 22353810 Free PMC article.
-
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.Am J Pathol. 2010 Nov;177(5):2379-86. doi: 10.2353/ajpath.2010.100354. Epub 2010 Oct 1. Am J Pathol. 2010. PMID: 20889570 Free PMC article.
-
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.Oncogene. 2009 Dec 3;28(48):4306-16. doi: 10.1038/onc.2009.280. Epub 2009 Sep 14. Oncogene. 2009. PMID: 19749790 Free PMC article.
-
LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.Br J Cancer. 2022 Oct;127(7):1239-1253. doi: 10.1038/s41416-022-01902-7. Epub 2022 Jul 21. Br J Cancer. 2022. PMID: 35864158 Free PMC article.
-
The roles of FGFR3 and c-MYC in urothelial bladder cancer.Discov Oncol. 2024 Jul 20;15(1):295. doi: 10.1007/s12672-024-01173-z. Discov Oncol. 2024. PMID: 39031286 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources